C. Sue Richards

6.5k citations

45 papers · 3.8k indexed · 4 hit papers · h-index 22

Genetics top 0.5%
- Genomics and Rare Diseases 13
- BRCA gene mutations in cancer 6
- Genomic variations and chromosomal abnormalities 4
Cancer Research top 5%
Cellular and Molecular Neuroscience top 5%
- Genetic Neurodegenerative Diseases 10
Pathology and Forensic Medicine top 5%
- Genetic factors in colorectal cancer 8
Molecular Biology top 5%
- DNA Repair Mechanisms 7
- Mitochondrial Function and Pathology 6
Pulmonary and Respiratory Medicine
- Cystic Fibrosis Research Advances 7

Co-authors: Sherri J. Bale Michael S. Watson Wayne W. Grody David T. Miller Wendy K. Chung Christa Lese Martin Teri E. Klein Kent D. McKelvey
Cited by: Genetics Cancer Research Cellular and Molecular Neuroscience
Journals: Proceedings of the National Academy of Sciences (1 paper)Nature Genetics (1 paper)Neurology (3 papers)
Partner nations: United States Canada Poland

In The Last Decade

C. Sue Richards

45 papers receiving 3.7k citations

Hit Papers

align trajectories log scale

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

2023 Genetics in Medicine
2021 Genetics in Medicine
2016 Genetics in Medicine
2008 Genetics in Medicine

Peers

Countries citing papers authored by C. Sue Richards

Since Specialization

Citations

This map shows the geographic impact of C. Sue Richards's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Sue Richards with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Sue Richards more than expected).

Fields of papers citing papers by C. Sue Richards

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Sue Richards. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Sue Richards. The network helps show where C. Sue Richards may publish in the future.

Co-authorship network

The 25 scholars most cited alongside C. Sue Richards, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with C. Sue Richards Line = papers co-authored together C. Sue Richards links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	ACMG SF v3.3 list for reporting of secondary findings in clinical exome and genome sequencing: A policy statement of the American College of Medical Genetics and Genomics (ACMG) Genetics in Medicine ·Kristy Lee,Noura S. Abul‐Husn,Laura M. Amendola,Kyle B. Brothers,Wendy K. Chung,Michael H. Gollob,Allan Gordon,Steven M. Harrison,Ray E. Hershberger,Marilyn M. Li,Deborah Ondrasik,C. Sue Richards,Andrew B. Stergachis,Douglas R. Stewart,Christa Lese Martin,David T. Miller	2025	6
2	Consideration of disease penetrance in the selection of secondary findings gene-disease pairs: A policy statement of the American College of Medical Genetics and Genomics (ACMG) Genetics in Medicine ·Allan Gordon,Kristy Lee,Noura S. Abul‐Husn,Laura M. Amendola,Kyle B. Brothers,Wendy K. Chung,Michael H. Gollob,Steven M. Harrison,Ray E Hershberger,C. Sue Richards,Douglas R. Stewart,Christa Lese Martin,David T. Miller	2024	8
3	An Educational Assessment of Evidence Used for Variant Classification Journal of Molecular Diagnostics ·Elaine Lyon,Robyn Temple‐Smolkin,Madhuri Hegde,Julie M. Gastier‐Foster,Glenn E. Palomaki,C. Sue Richards	2022	4
4	Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2021 update: a policy statement of the American College of Medical Genetics and Genomics (ACMG) Genetics in Medicine ·David T. Miller,Kristy Lee,Allan Gordon,Laura M. Amendola,Kathy Adelman,Sherri J. Bale,Wendy K. Chung,Michael H. Gollob,Steven M. Harrison,Gail E. Herman,Ray E. Hershberger,Teri E. Klein,Kent D. McKelvey,C. Sue Richards,Christopher N. Vlangos,Douglas R. Stewart,Michael S. Watson,Christa Lese Martin	2021	142
5	A case for expanding carrier testing to include actionable X‐linked disorders Clinical Case Reports ·Alan F. Rope,Tia L. Kauffman,Pat Himes,Laura M. Amendola,Sumit Punj,Yassmine Akkari,Amiee Potter,James V. Davis,Jennifer L. Schneider,Jacob A. Reiss,Mari J. Gilmore,Carmit K. McMullen,Deborah A. Nickerson,C. Sue Richards,Gail P. Jarvik,Benjamin S. Wilfond,Katrina A.B. Goddard	2018	2
6	Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomicsbreakdown → Genetics in Medicine ·Sarah S. Kalia,Kathy Adelman,Sherri J. Bale,Wendy K. Chung,Christine M. Eng,James P. Evans,Gail E. Herman,Sophia B. Hufnagel,Teri E. Klein,Bruce R. Korf,Kent D. McKelvey,Kelly E. Ormond,C. Sue Richards,Christopher N. Vlangos,Michael S. Watson,Christa Lese Martin,David T. Miller	2016	1023
7	Molecular genetic testing for cystic fibrosis: laboratory performance on the College of American Pathologists external proficiency surveys Genetics in Medicine ·Elaine Lyon,Iris Schrijver,Karen E. Weck,Andrea Ferreira‐Gonzalez,C. Sue Richards,Glenn E. Palomaki	2014	9
8	Risk categorization for oversight of laboratory-developed tests for inherited conditions Genetics in Medicine ·Kristin G. Monaghan,Judith Benkendorf,Athena M. Cherry,Susan J. Gross,C. Sue Richards,V. Reid Sutton,Michael S. Watson	2013	11
9	Assessing the analytic validity of molecular testing for Huntington disease using data from an external proficiency testing survey Genetics in Medicine ·Glenn E. Palomaki,C. Sue Richards	2012	13
10	Development of genomic reference materials for Huntington disease genetic testing Genetics in Medicine ·Lisa V. Kalman,Monique Johnson,Jeanne C. Beck,Elizabeth Berry‐Kravis,Arlene Buller,Brett Casey,Gerald L. Feldman,James H. Handsfield,John P. Jakupciak,Samantha Maragh,Karla J. Matteson,Kasinathan Muralidharan,Kristy L. Richie,Elizabeth M. Rohlfs,Frederick V. Schaefer,Tina Sellers,Elaine Spector,C. Sue Richards	2007	16
11	Technical standards and guidelines: Venous thromboembolism (Factor V Leiden and prothrombin 20210G>A testing): A disease-specific supplement to the standards and guidelines for clinical genetics laboratories Genetics in Medicine ·Elaine Spector,Wayne W. Grody,Carla J. Matteson,Glenn E. Palomaki,Daniel B. Bellissimo,Daynna J. Wolff,Linda Bradley,Thomas W. Prior,Gerald L. Feldman,Bradley W. Popovich,Michael S. Watson,C. Sue Richards	2005	33
12	Cystic fibrosis population carrier screening: 2004 revision of American College of Medical Genetics mutation panel Genetics in Medicine ·Michael S. Watson,Garry R. Cutting,Robert J. Desnick,Deborah A. Driscoll,K. Klinger,Michael T. Mennuti,Glenn E. Palomaki,Bradley W. Popovich,Victoria M. Pratt,Elizabeth M. Rohlfs,Charles M. Strom,C. Sue Richards,David R. Witt,Wayne W. Grody	2004	315
13	Analytic validity of cystic fibrosis testing: A preliminary estimate Genetics in Medicine ·Glenn E. Palomaki,Linda Bradley,C. Sue Richards,James E. Haddow	2003	19
14	Diagnostic DNA Testing for X-Linked Ocular Albinism ( OA1 ) with a Hierarchical Mutation Screening Protocol Genetic Testing ·Madhuri Hegde,Richard A. Lewis,C. Sue Richards	2002	7
15	Detection of Sequence Variations in the Adenomatous Polyposis Coli ( APC ) Gene Using Denaturing High-Performance Liquid Chromatography Genetic Testing ·Guohao Wu,Wei Wu,Madhuri Hegde,Matthew Fawkner,Belinda Chong,Donald R. Love,Li Su,Patrick M. Lynch,Karen Snow,C. Sue Richards	2001	30
16	Ashkenazi Jewish Population Frequency of the Bloom Syndrome Gene 2281Δ6ins7 Mutation Genetic Testing ·Benjamin B. Roa,CARLO V. SAVINO,C. Sue Richards	1999	26
17	Estimated Contribution of Known Ataxia Genes in Ataxia Patients Undergoing DNA Testing Genetic Testing ·Preethi H. Gunaratne,C. Sue Richards	1997	3
18	Population-specific screening by mutation analysis for diseases frequent in Ashkenazi Jews Human Mutation ·J Demarchi,C. Thomas Caskey,C. Sue Richards	1996	22
19	Molecular detection of new mutations, resolution of ambiguous results and complex genetic counseling issues in Huntington disease American Journal of Medical Genetics ·Raye Lynn Alford,Tetsuo Ashizawa,Joseph Jankovic,C. Thomas Caskey,C. Sue Richards	1996	7
20	Differentiation of schistosomes by species, strain, and sex by using cloned DNA markers. Proceedings of the National Academy of Sciences ·Thomas F. McCutchan,Andrew J.G. Simpson,J A Mullins,Alan Sher,T E Nash,Fred A. Lewis,C. Sue Richards	1984	72

About C. Sue Richards

C. Sue Richards is a scholar working on Genetics, Cellular and Molecular Neuroscience and Internal Medicine, having authored 45 papers that have together received 3.8k indexed citations. Recurring topics across this work include Genomics and Rare Diseases (13 papers), Genetic Neurodegenerative Diseases (10 papers), Genetic factors in colorectal cancer (8 papers), DNA Repair Mechanisms (7 papers), Cystic Fibrosis Research Advances (7 papers), Mitochondrial Function and Pathology (6 papers), BRCA gene mutations in cancer (6 papers) and Genomic variations and chromosomal abnormalities (4 papers). The work is most often cited by research in Genetics (2.1k citations), Cancer Research (499 citations) and Cellular and Molecular Neuroscience (460 citations). C. Sue Richards has collaborated with scholars based in United States, Canada and Poland. Frequent co-authors include Sherri J. Bale, Michael S. Watson, Wayne W. Grody, David T. Miller, Wendy K. Chung, Christa Lese Martin, Teri E. Klein, Kent D. McKelvey, Gail E. Herman and Christopher N. Vlangos. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nature Genetics and Neurology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact